Suppr超能文献

经导管主动脉瓣植入术后传导障碍患者的电生理研究指导下的永久性起搏器植入。

Electrophysiological Study-Guided Permanent Pacemaker Implantation in Patients With Conduction Disturbances Following Transcatheter Aortic Valve Implantation.

机构信息

Univ Rennes, CHU Rennes, Inserm, LTSI - UMR1099, F 35000 Rennes, France.

Univ Rennes, CHU Rennes, Inserm, LTSI - UMR1099, F 35000 Rennes, France.

出版信息

Am J Cardiol. 2021 Jun 15;149:78-85. doi: 10.1016/j.amjcard.2021.03.014. Epub 2021 Mar 20.

Abstract

Conduction disturbances remain common following transcatheter aortic valve implantation (TAVI). Aside from high-degree atrioventricular block (HAVB), their optimal management remains elusive. Invasive electrophysiological studies (EPS) may help stratify patients at low or high risk of HAVB allowing for an early discharge or permanent pacemaker (PPM) implantation among patients with conduction disturbances. We evaluated the safety and diagnostic performances of an EPS-guided PPM implantation strategy among TAVI recipients with conduction disturbances not representing absolute indications for PPM. All patients who underwent TAVI at a single expert center from June 2017 to July 2020 who underwent an EPS during the index hospitalization were included in the present study. False negative outcomes were defined as patients discharged without PPM implantation who required PPM for HAVB within 6 months of the initial EPS. False positive outcomes were defined as patients discharged with a PPM with a ventricular pacing percentage <1% at follow-up. A total of 78 patients were included (median age 83.5, 39% female), among whom 35 patients (45%) received a PPM following EPS. The sensitivity, specificity, positive and negative predictive values of the EPS-guided PPM implantation strategy were 100%, 89.6%, 81.5%, and 100%, respectively. Six patients suffered a mechanical HAVB during EPS and received a PPM. These 6 patients showed PPM dependency at follow-up. In conclusion, an EPS-guided PPM implantation strategy for managing post-TAVI conduction disturbances appears effective to identify patients who can be safely discharged without PPM implantation.

摘要

经导管主动脉瓣置换术(TAVI)后传导障碍仍然很常见。除了高度房室传导阻滞(HAVB)外,其最佳治疗方法仍难以捉摸。侵入性电生理研究(EPS)可以帮助分层低风险或高风险的 HAVB 患者,以便在传导障碍患者中尽早出院或植入永久性起搏器(PPM)。我们评估了在 TAVI 接受者中进行 EPS 指导的 PPM 植入策略的安全性和诊断性能,这些接受者的传导障碍不代表 PPM 的绝对指征。本研究纳入了 2017 年 6 月至 2020 年 7 月在一家专家中心接受 TAVI 治疗并在住院期间接受 EPS 的所有患者。假阴性结果定义为未植入 PPM 但在初始 EPS 后 6 个月内因 HAVB 需要 PPM 的患者。假阳性结果定义为在随访期间心室起搏百分比<1%的患者携带 PPM 出院。共纳入 78 例患者(中位年龄 83.5 岁,39%为女性),其中 35 例(45%)在 EPS 后接受了 PPM。EPS 指导的 PPM 植入策略的敏感性、特异性、阳性和阴性预测值分别为 100%、89.6%、81.5%和 100%。6 例患者在 EPS 期间发生机械性 HAVB,接受了 PPM。这 6 例患者在随访时显示对 PPM 的依赖性。总之,EPS 指导的 PPM 植入策略在管理 TAVI 后传导障碍方面似乎是有效的,可以识别出可以安全出院而无需植入 PPM 的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验